HAMILTON BEACH BRANDS HOLDING CO, 10-Q filed on 11/4/2026
Quarterly Report
v3.26.3
Cover Page - shares
9 Months Ended
Sep. 30, 2026
Oct. 30, 2026
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2026  
Document Transition Report false  
Entity File Number 001-38214  
Entity Registrant Name HAMILTON BEACH BRANDS HOLDING COMPANY  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 31-1236686  
Entity Address, Address Line One 4421 WATERFRONT DR.  
Entity Address, City or Town GLEN ALLEN  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 23060  
City Area Code (804)  
Local Phone Number 273-9777  
Title of 12(b) Security Class A Common Stock, Par Value $0.01 Per Share  
Trading Symbol HBB  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001709164  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Class A Common stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   9,856,278
Class B Common stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   3,582,852
v3.26.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Sep. 30, 2025
Current assets      
Cash and cash equivalents $ 92,539 $ 47,313 $ 17,175
Trade receivables, net 102,794 110,535 83,805
Inventory 138,715 133,833 174,801
Prepaid expenses and other current assets 13,938 13,052 15,466
Total current assets 347,986 304,733 291,247
Property, plant and equipment, net 22,795 30,253 33,172
Right-of-use lease assets 33,196 34,614 35,693
Goodwill 7,099 7,099 7,099
Deferred income taxes 3,568 3,607 7,556
Other non-current assets 13,699 17,318 17,615
Total assets 428,343 397,624 392,382
Current liabilities      
Accounts payable 109,774 86,376 106,458
Accrued compensation 12,366 13,956 8,800
Accrued product returns 7,151 7,875 6,452
Lease liabilities 5,921 5,497 5,497
Other current liabilities 7,949 9,529 8,409
Total current liabilities 143,161 123,233 135,616
Revolving credit agreements 25,000 50,000 50,000
Lease liabilities, non-current 34,148 36,416 37,628
Other long-term liabilities 5,270 5,130 5,090
Total liabilities 207,579 214,779 228,334
Stockholders’ equity      
Preferred stock, par value $0.01 per share 0 0 0
Capital in excess of par value 87,098 80,795 79,242
Treasury stock (38,938) (35,213) (34,124)
Retained earnings 179,683 143,888 126,953
Accumulated other comprehensive loss (7,236) (6,780) (8,177)
Total stockholders’ equity 220,764 182,845 164,048
Total liabilities and stockholders’ equity 428,343 397,624 392,382
Class A Common stock      
Stockholders’ equity      
Common stock 121 119 118
Class B Common stock      
Stockholders’ equity      
Common stock $ 36 $ 36 $ 36
v3.26.3
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2026
Dec. 31, 2025
Sep. 30, 2025
Statement of Financial Position [Abstract]      
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01
v3.26.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenue $ 140,262 $ 132,779 $ 404,857 $ 393,921
Cost of sales 101,717 104,753 252,624 297,993
Gross profit 38,545 28,026 152,233 95,928
Selling, general and administrative expenses 34,159 25,152 99,673 84,793
Operating profit (loss) 4,386 2,874 52,560 11,135
Interest (income) expense, net (555) 224 (1,897) 273
Other (income) expense, net (238) 625 (304) 294
Income (loss) before income taxes 5,179 2,025 54,761 10,568
Income tax expense (benefit) 1,637 372 13,972 2,657
Net income (loss) $ 3,542 $ 1,653 $ 40,789 $ 7,911
Basic earnings (loss) per share (in dollars per share) $ 0.26 $ 0.12 $ 3.02 $ 0.58
Diluted earnings (loss) per share (in dollars per share) $ 0.26 $ 0.12 $ 3.02 $ 0.58
Basic weighted average shares outstanding (in shares) 13,444 13,488 13,504 13,591
Diluted weighted average shares outstanding (in shares) 13,456 13,508 13,519 13,610
v3.26.3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ 3,542 $ 1,653 $ 40,789 $ 7,911
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustment (596) 81 (477) 3,068
Cash flow hedging activity 497 94 1,061 (1,641)
Reclassification of hedging activities into earnings (876) (128) (1,028) (1,080)
Reclassification related to pension termination activity into earnings 0 0 0 48
Reclassification of pension adjustments into earnings (4) (2) (12) 5
Total other comprehensive income (loss), net of tax (979) 45 (456) 400
Comprehensive income (loss) $ 2,563 $ 1,698 $ 40,333 $ 8,311
v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net income (loss) $ 40,789 $ 7,911
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:    
Depreciation and amortization 8,078 3,772
Stock compensation expense 6,305 2,577
Other 1,370 (1,570)
Net changes in operating assets and liabilities:    
Trade receivables 7,819 35,351
Inventory (6,498) (47,634)
Other assets 6,879 10,856
Accounts payable 23,306 1,882
Other liabilities (7,577) (27,786)
Net cash provided by (used for) operating activities 80,471 (14,641)
Investing activities    
Expenditures for property, plant and equipment (1,175) (2,228)
Other (306) (278)
Net cash provided by (used for) investing activities (1,481) (2,506)
Financing activities    
Net additions (reductions) to revolving credit agreements (25,000) 0
Cash dividends paid (4,994) (4,821)
Purchase of treasury stock (3,725) (7,922)
Net cash provided by (used for) financing activities (33,719) (12,743)
Effect of exchange rate changes on cash and cash equivalents (45) 541
Cash and cash equivalents    
Increase (decrease) for the period 45,226 (29,349)
Balance at the beginning of the period 47,313 46,524
Balance at the end of the period $ 92,539 $ 17,175
v3.26.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Class A Common stock
Common Stock
Class B Common stock
Capital in Excess of Par Value
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2024 $ 165,903 $ 115 $ 36 $ 76,668 $ (26,202) $ 123,863 $ (8,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 1,805         1,805  
Issuance of common stock, net of conversions 0 3   (3)      
Purchase of treasury stock (3,373)       (3,373)    
Share-based compensation expense 1,156     1,156      
Cash dividends (1,585)         (1,585)  
Other comprehensive income (loss), net of tax (293)           (293)
Reclassification adjustment to net income (loss) (432)           (432)
Ending balance at Mar. 31, 2025 163,181 118 36 77,821 (29,575) 124,083 (9,302)
Beginning balance at Dec. 31, 2024 165,903 115 36 76,668 (26,202) 123,863 (8,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 7,911            
Purchase of treasury stock (7,900)            
Ending balance at Sep. 30, 2025 164,048 118 36 79,242 (34,124) 126,953 (8,177)
Beginning balance at Dec. 31, 2024 165,903 115 36 76,668 (26,202) 123,863 (8,577)
Ending balance at Dec. 31, 2025 182,845 119 36 80,795 (35,213) 143,888 (6,780)
Beginning balance at Mar. 31, 2025 163,181 118 36 77,821 (29,575) 124,083 (9,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 4,453         4,453  
Purchase of treasury stock (3,974)       (3,974)    
Share-based compensation expense 852     852      
Cash dividends (1,617)         (1,617)  
Other comprehensive income (loss), net of tax 1,545           1,545
Reclassification adjustment to net income (loss) (465)           (465)
Ending balance at Jun. 30, 2025 163,975 118 36 78,673 (33,549) 126,919 (8,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 1,653         1,653  
Purchase of treasury stock (575)       (575)    
Share-based compensation expense 569     569      
Cash dividends (1,619)         (1,619)  
Other comprehensive income (loss), net of tax 175           175
Reclassification adjustment to net income (loss) (130)           (130)
Ending balance at Sep. 30, 2025 164,048 118 36 79,242 (34,124) 126,953 (8,177)
Beginning balance at Dec. 31, 2025 182,845 119 36 80,795 (35,213) 143,888 (6,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 3,539         3,539  
Issuance of common stock, net of conversions 0 2   (2)      
Purchase of treasury stock (1,206)       (1,206)    
Share-based compensation expense 1,186     1,186      
Cash dividends (1,629)         (1,629)  
Other comprehensive income (loss), net of tax (1)           (1)
Reclassification adjustment to net income (loss) 35           35
Ending balance at Mar. 31, 2026 184,769 121 36 81,979 (36,419) 145,798 (6,746)
Beginning balance at Dec. 31, 2025 182,845 119 36 80,795 (35,213) 143,888 (6,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 40,789            
Purchase of treasury stock (3,700)            
Ending balance at Sep. 30, 2026 220,764 121 36 87,098 (38,938) 179,683 (7,236)
Beginning balance at Mar. 31, 2026 184,769 121 36 81,979 (36,419) 145,798 (6,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 33,708         33,708  
Purchase of treasury stock (1,957)       (1,957)    
Share-based compensation expense 1,410     1,410      
Cash dividends (1,685)         (1,685)  
Other comprehensive income (loss), net of tax 684           684
Reclassification adjustment to net income (loss) (195)           (195)
Ending balance at Jun. 30, 2026 216,734 121 36 83,389 (38,376) 177,821 (6,257)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 3,542         3,542  
Purchase of treasury stock (562)       (562)    
Share-based compensation expense 3,709     3,709      
Cash dividends (1,680)         (1,680)  
Other comprehensive income (loss), net of tax (99)           (99)
Reclassification adjustment to net income (loss) (880)           (880)
Ending balance at Sep. 30, 2026 $ 220,764 $ 121 $ 36 $ 87,098 $ (38,938) $ 179,683 $ (7,236)
v3.26.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares
3 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Statement of Stockholders' Equity [Abstract]            
Cash dividends (in dollars per share) $ 0.125 $ 0.125 $ 0.12 $ 0.12 $ 0.12 $ 0.115
v3.26.3
Basis of Presentation and Recently Issued Accounting Standards
9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Recently Issued Accounting Standards Basis of Presentation and Recently Issued Accounting Standards
Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”).

We are a leading designer, marketer and distributor of a wide range of brand name small electric household and specialty housewares appliances, and commercial products for restaurants, fast food chains, bars and hotels, and a provider of connected devices and software for home healthcare management.

Our operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Certain prior period amounts have been reclassified to conform to the current period classification. These reclassifications had no effect on the reported operating profit, net income, or stockholders’ equity.

Operating results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the remainder of the year as our revenue typically increases during the second half of the year and peaks during the fourth quarter due to the fall holiday-selling season. Accordingly, quarter-to-quarter comparisons of our past operating results are meaningful only when comparing equivalent time periods, if at all.

We maintain a $125.0 million senior secured floating-rate revolving credit facility (the “HBB Facility”) that expires on December 13, 2029. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months.

Recently Issued Accounting Standards Not Yet Adopted

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40),” which requires additional information to be disclosed about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
In September 2025, the FASB issued ASU 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software,” which modernizes previously written guidance around internal-use software costs by eliminating accounting consideration of software project development stages and provides for cost capitalization when management has authorized and committed funding to the project and that the project is considered ‘probable’ of completion and the software used to perform the function as intended, along with prescriptive disclosure requirements associated with internal-use software costs to be consistent with Subtopic 360-10, “Property, Plant and Equipment” regardless of how those costs are presented in the financial statements. The amendments are effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The amendment may be applied either retrospectively or prospectively or on a modified prospective basis prescribed by the ASU. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow Scope Improvements.” The update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The amendments are effective for annual periods beginning after December 15, 2027, including interim periods within that annual period. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.

Accounts Payable - Supplier Finance Program

The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements.

As of September 30, 2026, December 31, 2025 and September 30, 2025, the Company had $43.6 million, $29.9 million and $54.4 million, respectively, in outstanding payment obligations to the third-party financial institution that are presented in accounts payable on the Consolidated Balance Sheets. There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party financial institution based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash provided by operating activities in the Consolidated Statements of Cash Flows.

The agreement limits payment obligations owed by the Company but sold by participating suppliers to $65.0 million. Of the amounts owed by the Company referenced above that are presented in accounts payable, participating suppliers have sold $32.7 million, $21.8 million and $44.4 million, as of September 30, 2026, December 31, 2025 and September 30, 2025, respectively.
v3.26.3
Transfer of Financial Assets
9 Months Ended
Sep. 30, 2026
Transfers and Servicing [Abstract]  
Transfer of Financial Assets Transfer of Financial Assets
The Company previously had an arrangement with a financial institution to sell certain U.S. trade receivables of a single customer on a non-recourse basis. The Company exited the arrangement during 2026. Under the terms of the agreement, the Company received cash proceeds and retained no rights or interest and had no obligations with respect to the sold receivables. These transactions, which were accounted for as sold receivables, resulted in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $0.0 million and $4.3 million of trade receivables during the three and nine months ended September 30, 2026, respectively, $35.8 million and $102.4 million during the three and nine months ended September 30, 2025, respectively, and $145.0 million during the year ended December 31, 2025. The decrease in derecognized trade receivables for the three and nine months ended September 30, 2026 is due to the Company’s decision to exit the agreement in 2026. The loss incurred on sold receivables in the Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 was not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities in the Consolidated Statements of Cash Flows.
v3.26.3
Fair Value Disclosure
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Fair Value Disclosure Fair Value Disclosure
The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:
DescriptionBalance Sheet LocationSEPTEMBER 30
2026
DECEMBER 31
2025
SEPTEMBER 30
2025
Assets:
Interest rate swap agreements
CurrentPrepaid expenses and other current assets$699 $831 $841 
Long-termOther non-current assets874 1,199 1,419 
$1,573 $2,030 $2,260 
Liabilities:
Foreign currency exchange contracts
CurrentOther current liabilities— 126 675 
$— $126 $675 

The Company measures its derivatives at fair value using significant observable inputs, which is Level 2 as defined in the fair value hierarchy. The Company uses a present value technique that incorporates the Secured Overnight Financing Rate (SOFR) swap curve, foreign currency spot rates and foreign currency forward rates to value its derivatives, including its interest rate swap agreements and foreign currency exchange contracts. The Company also incorporates the effect of HBB and counterparty credit risk into the valuation.

Other Fair Value Measurement Disclosures

The carrying amounts of cash and cash equivalents, trade receivables and accounts payable approximate fair value due to the short-term maturities of these instruments.

The carrying amount of borrowings outstanding under the HBB Facility, including book overdrafts, approximates fair value and was determined using current rates offered for similar obligations taking into account the Company’s credit risk, which is Level 2 as defined in the fair value hierarchy.

The Company does not hold any Level 3 assets or liabilities and there were no transfers into or out of Levels 1, 2 or 3 during the three and nine months ended September 30, 2026.
v3.26.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Stockholders’ Equity Stockholders’ Equity
Capital Stock 

The following table sets forth the Company’s authorized capital stock information:
SEPTEMBER 30
2026
DECEMBER 31
2025
SEPTEMBER 30
2025
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 5,000 
Preferred stock outstanding— — — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 70,000 
Class A Common issued (1)(2)
12,100 11,870 11,849 
Treasury Stock (3)
2,244 2,052 1,980 
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized30,000 30,000 30,000 
Class B Common issued (1)
3,583 3,587 3,587 

(1) Class B Common converted to Class A Common were 1 and 4 shares during the three and nine months ended September 30, 2026, respectively, and 9 and 16 shares during the three and nine months ended September 30, 2025, respectively.

(2) The Company issued Class A Common of 16 and 226 shares during the three and nine months ended September 30, 2026, respectively, and 19 and 357 shares during the three and nine months ended September 30, 2025, respectively.

(3) On February 20, 2026 and February 21, 2025, a total of 14 and 39 mandatory cashless-exercise-award shares of Class A Common, respectively, were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan.

Stock Repurchase Program: In November 2025, the Company’s Board of Directors (the “Board”) approved a stock repurchase program for the purchase of up to $25.0 million of the Company’s Class A Common outstanding starting January 1, 2026 and ending December 31, 2027. This program replaced the previous stock repurchase plan that started January 1, 2024 and ended December 31, 2025. During the three and nine months ended September 30, 2026, the Company repurchased 24,908 and 178,190 shares at prevailing market prices for an aggregate purchase price of $0.6 million and $3.5 million, respectively. During the three and nine months ended September 30, 2025, the Company repurchased 39,333 and 396,065 shares at prevailing market prices for an aggregate purchase price of $0.6 million and $7.2 million, respectively. During the year ended December 31, 2025, the Company repurchased 467,804 shares for an aggregate purchase price of $8.3 million. As of September 30, 2026, the Company had $21.5 million remaining authorized for repurchase.

Additionally, during the nine months ended September 30, 2026 and September 30, 2025, the Company withheld shares for tax payments due upon issuance of stock to employees under the Incentive Plan. During the nine months ended September 30, 2026 and September 30, 2025, the Company repurchased 13,575 and 39,121 shares, respectively, for an aggregate purchase price of $0.3 million and $0.7 million, respectively, pursuant to the Incentive Plan. There were no shares repurchased pursuant to the Incentive Plan during the three months ended September 30, 2026 and September 30, 2025.

The total combined share repurchases from the stock repurchase program and the Incentive Plan during the three and nine months ended September 30, 2026 was 24,908 and 191,765 shares, respectively, for an aggregate purchase price of $0.6 million and $3.7 million, respectively. The total combined share repurchases from the stock repurchase program and the Incentive Plan during the three and nine months ended September 30, 2025 was 39,333 and 435,186 shares, respectively, for an aggregate purchase price of $0.6 million and $7.9 million, respectively.
Accumulated Other Comprehensive Loss: The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:
Foreign CurrencyDeferred Gain (Loss) on Cash Flow Hedging Pension Plan AdjustmentTotal
Balance, January 1, 2026$(8,365)$1,096 $489 $(6,780)
Other comprehensive income (loss)(290)383 — 93 
Reclassification adjustment to net income (loss)— 80 (6)74 
Tax effects— (133)— (133)
Balance, March 31, 2026(8,655)1,426 483 (6,746)
Other comprehensive income (loss)409 364 — 773 
Reclassification adjustment to net income (loss)— (254)(2)(256)
Tax effects— (28)— (28)
Balance, June 30, 2026(8,246)1,508 481 (6,257)
Other comprehensive income (loss)(596)654 — 58 
Reclassification adjustment to net income (loss)— (1,155)(4)(1,159)
Tax effects— 122 — 122 
Balance, September 30, 2026$(8,842)$1,129 $477 $(7,236)
Balance, January 1, 2025$(12,279)$3,572 $130 $(8,577)
Other comprehensive income (loss)327 (861)— (534)
Reclassification adjustment to net income (loss)— (654)64 (590)
Tax effects— 415 (16)399 
Balance, March 31, 2025(11,952)2,472 178 (9,302)
Other comprehensive income (loss)2,660 (1,567)— 1,093 
Reclassification adjustment to net income (loss)— (637)7 (630)
Tax effects— 617 — 617 
Balance, June 30, 2025(9,292)885 185 (8,222)
Other comprehensive income (loss)81 114 — 195 
Reclassification adjustment to net income (loss)— (151)(2)(153)
Tax effects— 3 — 3 
Balance, September 30, 2025$(9,211)$851 $183 $(8,177)

During the third quarter of 2026, the Company terminated interest rate swap agreements with an aggregate notional amount of $25.0 million in connection with the repayment of a portion of its variable-rate debt. As a result, approximately $0.9 million of previously deferred gains associated with the terminated cash flow hedges were reclassified from accumulated other comprehensive income into earnings.
v3.26.3
Revenue
9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services, which includes an estimate for variable consideration.

The Company’s warranty program to the consumer consists generally of an assurance-type limited warranty for electric appliances, with the majority of products having a warranty of one to three years. There is no guarantee to the consumer as the Company may repair or replace, at its discretion, products returned under warranty. Accordingly, the Company determined that no separate performance obligation exists.

Most of the Company’s products are not sold with a general right of return. Subject to certain terms and conditions, however, the Company will agree to accept a portion of products sold that, based on historical experience, are estimated to be returned for reasons such as product failure and excess inventory stocked by the customer. Product returns, customer programs and incentive offerings, including special pricing agreements, price competition, promotions and other volume-based incentives are accounted for as variable consideration.

A description of revenue sources and performance obligations for the Company are as follows:

Consumer and Commercial product revenue
Transactions with both consumer and commercial customers generally originate upon the receipt of a purchase order from a customer, which in some cases are governed by master sales agreements, specifying product(s) that the customer desires. Contracts for product revenue have an original duration of one year or less, and payment terms are generally standard and based on customer creditworthiness. Revenue from product sales is recognized at the point in time when control transfers to the customer, which is either when a product is shipped from a Company facility, or delivered to customers, depending on the shipping terms. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company evaluated such agreements with its customers and determined returns and price concessions should be accounted for as variable consideration.

Consumer product revenue consists of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. A majority of this revenue is in North America.

Commercial product revenue consists of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales are in the U.S., and the remaining is in markets across the globe.

License revenue
From time to time, the Company enters into licensing agreements which grant the right to use certain of the Company’s intellectual property (“IP”) in connection with designing, manufacturing, distributing, advertising, promoting and selling the licensees’ products during the term of the agreement. The IP that is licensed generally consists of trademarks, trade names, patents, trade dress, logos and/or products (the “Licensed IP”). In exchange for granting the right to use the Licensed IP, the Company receives a royalty payment, which is a function of (1) the total net sales of products that use the Licensed IP and (2) the royalty percentage that is stated in the licensing agreement. The Company recognizes revenue at the later of when the subsequent sales occur or when the performance obligation is satisfied over time.

Additionally, the Company enters into agreements which grant the right to use software for healthcare management. The Company receives a license payment which is recognized when the performance obligation is satisfied over time or as usage occurs based on the contract with the customer.

Lease revenue
The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies and is accounted for under Accounting Standards Codification 842, Leases as operating leases.
The following table sets forth the Company’s revenue on a disaggregated basis for the three and nine months ended September 30:
THREE MONTHS ENDED
SEPTEMBER 30
NINE MONTHS ENDED
SEPTEMBER 30
2026202520262025
Type of good or service:
  Consumer products$121,965 $113,838 $350,285 $340,781 
  Commercial products14,187 15,493 42,408 42,428 
  Licensing2,037 2,041 6,174 6,809 
  Leasing2,073 1,407 5,990 3,903 
     Total revenues$140,262 $132,779 $404,857 $393,921 
v3.26.3
Contingencies
9 Months Ended
Sep. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, environmental and other claims. Although it is difficult to predict the ultimate outcome of these proceedings and claims, the Company believes the ultimate disposition of these matters will not have a material adverse effect on the financial condition, results of operations or cash flows of the Company. Any costs that the Company estimates will be paid as a result of these claims are accrued when the liability is considered probable and the amount of such costs can be reasonably estimated. The Company does not accrue liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated or when the liability is believed to be only reasonably possible or remote. For contingencies where an unfavorable outcome is probable or reasonably possible and which are material, the Company discloses the nature of the contingency and, in some circumstances, an estimate of the possible loss.

Tariff matters (IEEPA)

On February 20, 2026, the United States Supreme Court (“Court”) issued a ruling that the International Emergency Economic Powers Act (“IEEPA”) does not authorize the U.S. President to impose tariffs. The Court’s ruling invalidated tariffs previously implemented by the U.S. Presidential Administration pursuant to IEEPA (“IEEPA Ruling”). As a result of this ruling, the Company began filing refund claims through the U.S. Customs and Border Protection’s Consolidated Administration and Processing of Entries system. The Company has elected to apply a gain contingency model to account for potential recoveries of previously paid IEEPA tariffs (“IEEPA Tariff Refunds”) and any related interest received. Under this model, a gain contingency is not recognized in the consolidated financial statements until the gain is realized or realizable. Any remaining recovery, when recognized, would be reflected as a reduction of inventory to the extent the related goods remain on hand, or as a reduction to cost of sales for amounts related to goods already sold. During the three and nine months ended September 30, 2026, the Company received $0.0 million and $36.5 million, respectively, of IEEPA Tariff Refunds and recognized such refunds as a reduction of cost of sales in the Consolidated Statements of Operations. During the three and nine months ended September 30, 2026, the Company also received $0.0 million and $1.2 million, respectively, of interest associated with the IEEPA Tariff Refunds, which was recognized within interest (income) expense, net.

Environmental matters

The Company is investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses the Company has acquired. The estimate of future investigation and remediation costs is primarily based on variables associated with site clean-up, including, but not limited to, physical characteristics of the site, the nature and extent of the contamination and applicable regulatory programs and remediation standards. The Company continues to monitor environmental matters and as of September 30, 2026, management has determined that such obligations are not material to the Company’s financial position, results of operations, or cash flows.
v3.26.3
Income Taxes
9 Months Ended
Sep. 30, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company’s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period.

The effective tax rate was 31.6% and 18.4% for the three months ended September 30, 2026 and 2025, respectively, and 25.5% and 25.1% for the nine months ended September 30, 2026 and 2025, respectively. The lower effective tax rates in 2025 for both periods are primarily due to a favorable discrete tax benefit recognized in the third quarter of 2025.
v3.26.3
Segment Information
9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company’s operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health. These segments are organized principally by product and service category. The Company’s reportable segments are determined based on (1) financial information reviewed by the chief operating decision maker (“CODM”), (2) operational structure of the Company which is designed and managed to share resources across the entire suite of products offered by the business, and (3) the basis upon which the CODM makes resource allocation decisions. The CODM for both segments is the President and Chief Executive Officer of the Company. The CODM utilizes the segment operating profit (loss) to assess profitability and performance of actual results compared to forecasts.

The types of products and services from which each reportable segment derives its revenues are as follows:

Home and Commercial Products
Our Home and Commercial Products segment includes consumer product revenue, primarily concentrated in North America, consisting of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. Also included in this segment is commercial product revenue consisting of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales are in the U.S., and the remaining is in markets across the globe.

Health
Our Health segment includes lease revenue in the U.S. and globally associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue associated with agreements which grant customers the right to use software for healthcare management.
The table below presents the revenues and significant expenses of the two reportable segments along with a reconciliation of segment profit (loss) to consolidated income (loss) before income taxes. Total assets by segment are not reported as the CODM does not regularly review asset information by segment.

THREE MONTHS ENDED SEPTEMBER 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$137,707 $2,555 $140,262 $130,892 $1,887 $132,779 
Less:
Cost of sales101,065 652 101,717 104,266 487 104,753 
Selling, general and administrative expenses32,435 1,724 34,159 23,924 1,228 25,152 
Segment profit (loss)$4,207 $179 $4,386 $2,702 $172 $2,874 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(555)224 
Other (income) expense, net(238)625 
Income (loss) before income taxes$5,179 $2,025 

NINE MONTHS ENDED SEPTEMBER 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$397,490 $7,367 $404,857 $388,792 $5,129 $393,921 
Less:
Cost of sales250,837 1,787 252,624 296,641 1,352 297,993 
Selling, general and administrative expenses94,463 5,210 99,673 79,452 5,341 84,793 
Segment profit (loss)$52,190 $370 $52,560 $12,699 $(1,564)$11,135 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(1,897)273 
Other (income) expense, net(304)294 
Income (loss) before income taxes$54,761 $10,568 
v3.26.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.3
Basis of Presentation and Recently Issued Accounting Standards (Policies)
9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”).

We are a leading designer, marketer and distributor of a wide range of brand name small electric household and specialty housewares appliances, and commercial products for restaurants, fast food chains, bars and hotels, and a provider of connected devices and software for home healthcare management.

Our operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Operating results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the remainder of the year as our revenue typically increases during the second half of the year and peaks during the fourth quarter due to the fall holiday-selling season. Accordingly, quarter-to-quarter comparisons of our past operating results are meaningful only when comparing equivalent time periods, if at all.
Reclassification
Certain prior period amounts have been reclassified to conform to the current period classification. These reclassifications had no effect on the reported operating profit, net income, or stockholders’ equity.
Recently Issued Accounting Standards Not Yet Adopted
Recently Issued Accounting Standards Not Yet Adopted

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40),” which requires additional information to be disclosed about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
In September 2025, the FASB issued ASU 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software,” which modernizes previously written guidance around internal-use software costs by eliminating accounting consideration of software project development stages and provides for cost capitalization when management has authorized and committed funding to the project and that the project is considered ‘probable’ of completion and the software used to perform the function as intended, along with prescriptive disclosure requirements associated with internal-use software costs to be consistent with Subtopic 360-10, “Property, Plant and Equipment” regardless of how those costs are presented in the financial statements. The amendments are effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The amendment may be applied either retrospectively or prospectively or on a modified prospective basis prescribed by the ASU. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow Scope Improvements.” The update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The amendments are effective for annual periods beginning after December 15, 2027, including interim periods within that annual period. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
Accounts Payable - Supplier Finance Program
Accounts Payable - Supplier Finance Program
The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements.
v3.26.3
Fair Value Disclosure (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:
DescriptionBalance Sheet LocationSEPTEMBER 30
2026
DECEMBER 31
2025
SEPTEMBER 30
2025
Assets:
Interest rate swap agreements
CurrentPrepaid expenses and other current assets$699 $831 $841 
Long-termOther non-current assets874 1,199 1,419 
$1,573 $2,030 $2,260 
Liabilities:
Foreign currency exchange contracts
CurrentOther current liabilities— 126 675 
$— $126 $675 
v3.26.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Schedule of Capital Stock
The following table sets forth the Company’s authorized capital stock information:
SEPTEMBER 30
2026
DECEMBER 31
2025
SEPTEMBER 30
2025
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 5,000 
Preferred stock outstanding— — — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 70,000 
Class A Common issued (1)(2)
12,100 11,870 11,849 
Treasury Stock (3)
2,244 2,052 1,980 
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized30,000 30,000 30,000 
Class B Common issued (1)
3,583 3,587 3,587 

(1) Class B Common converted to Class A Common were 1 and 4 shares during the three and nine months ended September 30, 2026, respectively, and 9 and 16 shares during the three and nine months ended September 30, 2025, respectively.

(2) The Company issued Class A Common of 16 and 226 shares during the three and nine months ended September 30, 2026, respectively, and 19 and 357 shares during the three and nine months ended September 30, 2025, respectively.

(3) On February 20, 2026 and February 21, 2025, a total of 14 and 39 mandatory cashless-exercise-award shares of Class A Common, respectively, were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan.
Schedule of Accumulated Other Comprehensive Loss The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:
Foreign CurrencyDeferred Gain (Loss) on Cash Flow Hedging Pension Plan AdjustmentTotal
Balance, January 1, 2026$(8,365)$1,096 $489 $(6,780)
Other comprehensive income (loss)(290)383 — 93 
Reclassification adjustment to net income (loss)— 80 (6)74 
Tax effects— (133)— (133)
Balance, March 31, 2026(8,655)1,426 483 (6,746)
Other comprehensive income (loss)409 364 — 773 
Reclassification adjustment to net income (loss)— (254)(2)(256)
Tax effects— (28)— (28)
Balance, June 30, 2026(8,246)1,508 481 (6,257)
Other comprehensive income (loss)(596)654 — 58 
Reclassification adjustment to net income (loss)— (1,155)(4)(1,159)
Tax effects— 122 — 122 
Balance, September 30, 2026$(8,842)$1,129 $477 $(7,236)
Balance, January 1, 2025$(12,279)$3,572 $130 $(8,577)
Other comprehensive income (loss)327 (861)— (534)
Reclassification adjustment to net income (loss)— (654)64 (590)
Tax effects— 415 (16)399 
Balance, March 31, 2025(11,952)2,472 178 (9,302)
Other comprehensive income (loss)2,660 (1,567)— 1,093 
Reclassification adjustment to net income (loss)— (637)7 (630)
Tax effects— 617 — 617 
Balance, June 30, 2025(9,292)885 185 (8,222)
Other comprehensive income (loss)81 114 — 195 
Reclassification adjustment to net income (loss)— (151)(2)(153)
Tax effects— 3 — 3 
Balance, September 30, 2025$(9,211)$851 $183 $(8,177)
v3.26.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table sets forth the Company’s revenue on a disaggregated basis for the three and nine months ended September 30:
THREE MONTHS ENDED
SEPTEMBER 30
NINE MONTHS ENDED
SEPTEMBER 30
2026202520262025
Type of good or service:
  Consumer products$121,965 $113,838 $350,285 $340,781 
  Commercial products14,187 15,493 42,408 42,428 
  Licensing2,037 2,041 6,174 6,809 
  Leasing2,073 1,407 5,990 3,903 
     Total revenues$140,262 $132,779 $404,857 $393,921 
v3.26.3
Segment Information (Tables)
9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
The table below presents the revenues and significant expenses of the two reportable segments along with a reconciliation of segment profit (loss) to consolidated income (loss) before income taxes. Total assets by segment are not reported as the CODM does not regularly review asset information by segment.

THREE MONTHS ENDED SEPTEMBER 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$137,707 $2,555 $140,262 $130,892 $1,887 $132,779 
Less:
Cost of sales101,065 652 101,717 104,266 487 104,753 
Selling, general and administrative expenses32,435 1,724 34,159 23,924 1,228 25,152 
Segment profit (loss)$4,207 $179 $4,386 $2,702 $172 $2,874 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(555)224 
Other (income) expense, net(238)625 
Income (loss) before income taxes$5,179 $2,025 

NINE MONTHS ENDED SEPTEMBER 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$397,490 $7,367 $404,857 $388,792 $5,129 $393,921 
Less:
Cost of sales250,837 1,787 252,624 296,641 1,352 297,993 
Selling, general and administrative expenses94,463 5,210 99,673 79,452 5,341 84,793 
Segment profit (loss)$52,190 $370 $52,560 $12,699 $(1,564)$11,135 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(1,897)273 
Other (income) expense, net(304)294 
Income (loss) before income taxes$54,761 $10,568 
v3.26.3
Basis of Presentation and Recently Issued Accounting Standards (Details)
$ in Millions
9 Months Ended
Sep. 30, 2026
USD ($)
segment
Dec. 31, 2025
USD ($)
Sep. 30, 2025
USD ($)
Basis of Presentation and Policies [Line Items]      
Number of operating segments | segment 2    
Number of reportable segments | segment 2    
Outstanding payment obligations, current $ 43.6 $ 29.9 $ 54.4
Limit on payment obligations 65.0    
Settlement of outstanding payment obligations 32.7 $ 21.8 $ 44.4
Letter of Credit | HBB Facility      
Basis of Presentation and Policies [Line Items]      
Line of credit facility, maximum borrowing capacity $ 125.0    
v3.26.3
Transfer of Financial Assets (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Transfers and Servicing [Abstract]          
Accounts receivable derecognized $ 0.0 $ 35.8 $ 4.3 $ 102.4 $ 145.0
Loss on sold receivables $ 0.0 $ 0.0 $ 0.0 $ 0.0  
v3.26.3
Fair Value Disclosure (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Sep. 30, 2025
Assets:      
Assets at fair value $ 1,573 $ 2,030 $ 2,260
Liabilities:      
Foreign currency exchange contracts 0 126 675
Liabilities at fair value 0 126 675
Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent      
Assets:      
Interest rate swap agreements 874 1,199 1,419
Balance Sheet Location [Axis]: us-gaap:PrepaidExpenseAndOtherAssetsCurrent      
Assets:      
Interest rate swap agreements $ 699 $ 831 $ 841
v3.26.3
Stockholders’ Equity - Schedule of Capital Stock (Details)
shares in Thousands
3 Months Ended 9 Months Ended
Feb. 20, 2026
shares
Feb. 21, 2025
shares
Sep. 30, 2026
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2026
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Dec. 31, 2025
$ / shares
shares
Class of Stock [Line Items]              
Preferred stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Preferred stock authorized (in shares)     5,000 5,000 5,000 5,000 5,000
Preferred stock outstanding (in shares)     0 0 0 0 0
Class A Common stock              
Class of Stock [Line Items]              
Common stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock authorized (in shares)     70,000 70,000 70,000 70,000 70,000
Common stock issued (in shares)     12,100 11,849 12,100 11,849 11,870
Treasury stock (in shares)     2,244 1,980 2,244 1,980 2,052
Class A common shares issued (in shares)     16 19 226 357  
Number of shares surrendered to satisfy tax withholding obligation (in shares) 14 39          
Class B Common stock              
Class of Stock [Line Items]              
Common stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock, convertible conversion ratio     1 1 1 1 1
Common stock authorized (in shares)     30,000 30,000 30,000 30,000 30,000
Common stock issued (in shares)     3,583 3,587 3,583 3,587 3,587
Class B common converted to Class A common (in shares)     1 9 4 16  
v3.26.3
Stockholders’ Equity - Stock Repurchase Program (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Nov. 30, 2025
Class of Stock [Line Items]                    
Shares repurchased (in shares) 24,908     39,333     191,765 435,186    
Shares repurchase price $ 562,000 $ 1,957,000 $ 1,206,000 $ 575,000 $ 3,974,000 $ 3,373,000 $ 3,700,000 $ 7,900,000    
2023 Stock Repurchase Program | Shares Outstanding Class A                    
Class of Stock [Line Items]                    
Approved repurchase amount                   $ 25,000,000.0
2026 and 2027 Stock Repurchase Plan                    
Class of Stock [Line Items]                    
Shares repurchased (in shares) 24,908     39,333     178,190 396,065 467,804  
Shares repurchase price $ 600,000     $ 600,000     $ 3,500,000 $ 7,200,000 $ 8,300,000  
Remaining authorized repurchase amount $ 21,500,000           $ 21,500,000      
Incentive Plan                    
Class of Stock [Line Items]                    
Shares repurchased (in shares) 0     0     13,575 39,121    
Shares repurchase price             $ 300,000 $ 700,000    
v3.26.3
Stockholders’ Equity - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning balance $ 216,734 $ 184,769 $ 182,845 $ 163,975 $ 163,181 $ 165,903
Other comprehensive income (loss) 58 773 93 195 1,093 (534)
Reclassification adjustment to net income (loss) (1,159) (256) 74 (153) (630) (590)
Tax effects 122 (28) (133) 3 617 399
Ending balance 220,764 216,734 184,769 164,048 163,975 163,181
Accumulated Other Comprehensive Income (Loss)            
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning balance (6,257) (6,746) (6,780) (8,222) (9,302) (8,577)
Ending balance (7,236) (6,257) (6,746) (8,177) (8,222) (9,302)
Foreign Currency            
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning balance (8,246) (8,655) (8,365) (9,292) (11,952) (12,279)
Other comprehensive income (loss) (596) 409 (290) 81 2,660 327
Reclassification adjustment to net income (loss) 0 0 0 0 0 0
Tax effects 0 0 0 0 0 0
Ending balance (8,842) (8,246) (8,655) (9,211) (9,292) (11,952)
Deferred Gain (Loss) on Cash Flow Hedging            
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning balance 1,508 1,426 1,096 885 2,472 3,572
Other comprehensive income (loss) 654 364 383 114 (1,567) (861)
Reclassification adjustment to net income (loss) (1,155) (254) 80 (151) (637) (654)
Tax effects 122 (28) (133) 3 617 415
Ending balance 1,129 1,508 1,426 851 885 2,472
Pension Plan Adjustment            
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning balance 481 483 489 185 178 130
Other comprehensive income (loss) 0 0 0 0 0 0
Reclassification adjustment to net income (loss) (4) (2) (6) (2) 7 64
Tax effects 0 0 0 0 0 (16)
Ending balance $ 477 $ 481 $ 483 $ 183 $ 185 $ 178
v3.26.3
Stockholders’ Equity - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Deferred gains reclassified to earnings $ 5,179 $ 2,025 $ 54,761 $ 10,568
Deferred Gain (Loss) on Cash Flow Hedging | Reclassification out of Accumulated Other Comprehensive Income        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Deferred gains reclassified to earnings 900      
Interest Rate Swap        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Notional amount of interest rate swap terminated $ 25,000      
v3.26.3
Revenue - Narrative (Details)
9 Months Ended
Sep. 30, 2026
Other products | Maximum  
Disaggregation of Revenue [Line Items]  
Warranty term (in years) 3 years
Other products | Minimum  
Disaggregation of Revenue [Line Items]  
Warranty term (in years) 1 year
Consumer products | Maximum  
Disaggregation of Revenue [Line Items]  
Revenue contract duration (in years) 1 year
Commercial products | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | United States  
Disaggregation of Revenue [Line Items]  
Concentration risk, percentage (as percent) 66.66%
Commercial products | Maximum  
Disaggregation of Revenue [Line Items]  
Revenue contract duration (in years) 1 year
v3.26.3
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Disaggregation of Revenue [Line Items]        
Leasing $ 2,073 $ 1,407 $ 5,990 $ 3,903
Total revenues 140,262 132,779 404,857 393,921
Consumer products        
Disaggregation of Revenue [Line Items]        
Revenue 121,965 113,838 350,285 340,781
Commercial products        
Disaggregation of Revenue [Line Items]        
Revenue 14,187 15,493 42,408 42,428
Licensing        
Disaggregation of Revenue [Line Items]        
Revenue $ 2,037 $ 2,041 $ 6,174 $ 6,809
v3.26.3
Contingencies (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Gain Contingencies [Line Items]        
Interest income $ 555 $ (224) $ 1,897 $ (273)
IEEPA Tariff Refund        
Gain Contingencies [Line Items]        
Tariff refunds recognized as a reduction of cost of sales 0   36,500  
Interest income $ 0   $ 1,200  
v3.26.3
Income Taxes (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Tax Disclosure [Abstract]        
Effective tax rate 31.60% 18.40% 25.50% 25.10%
v3.26.3
Segment Information - Narrative (Details)
9 Months Ended
Sep. 30, 2026
segment
Segment Reporting [Line Items]  
Number of operating segments 2
Number of reportable segments 2
Commercial products | United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk  
Segment Reporting [Line Items]  
Concentration risk, percentage (as percent) 66.66%
v3.26.3
Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]        
Revenue $ 140,262 $ 132,779 $ 404,857 $ 393,921
Less:        
Cost of sales 101,717 104,753 252,624 297,993
Selling, general and administrative expenses 34,159 25,152 99,673 84,793
Operating profit (loss) 4,386 2,874 52,560 11,135
Reconciliation of segment profit or (loss)        
Interest (income) expense, net (555) 224 (1,897) 273
Other (income) expense, net (238) 625 (304) 294
Income (loss) before income taxes 5,179 2,025 54,761 10,568
Operating segments        
Segment Reporting [Line Items]        
Revenue 140,262 132,779 404,857 393,921
Less:        
Cost of sales 101,717 104,753 252,624 297,993
Selling, general and administrative expenses 34,159 25,152 99,673 84,793
Operating profit (loss) 4,386 2,874 52,560 11,135
Operating segments | Home and Commercial Products        
Segment Reporting [Line Items]        
Revenue 137,707 130,892 397,490 388,792
Less:        
Cost of sales 101,065 104,266 250,837 296,641
Selling, general and administrative expenses 32,435 23,924 94,463 79,452
Operating profit (loss) 4,207 2,702 52,190 12,699
Operating segments | Health        
Segment Reporting [Line Items]        
Revenue 2,555 1,887 7,367 5,129
Less:        
Cost of sales 652 487 1,787 1,352
Selling, general and administrative expenses 1,724 1,228 5,210 5,341
Operating profit (loss) 179 172 370 (1,564)
Reconciling Items        
Reconciliation of segment profit or (loss)        
Interest (income) expense, net (555) 224 (1,897) 273
Other (income) expense, net $ (238) $ 625 $ (304) $ 294